FilingReader Intelligence
Zydus plant receives four USFDA inspection observations
August 13, 2025 at 04:19 PM UTC•By FilingReader AI
Zydus Lifesciences' formulation manufacturing plant in Baddi received four observations following a USFDA surveillance inspection from August 4-13.
No data integrity-related observations were found. The company said it will work with the USFDA to address the observations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:ZYDUSLIFE•Bombay Stock Exchange
News Alerts
Get instant email alerts when Zydus Lifesciences publishes news
Free account required • Unsubscribe anytime